Current management of juvenile nasopharyngeal angiofibroma: A tertiary center experience 1999-2007

Benjamin S. Bleier, David W. Kennedy, James N. Palmer, Alexander G Chiu, Jason D. Bloom, Bert W. O'Malley

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Background: Over the past 10 years, the management of juvenile nasopharyngeal angiofibroma (JNA) has been redefined because of the improvement of transnasal skull base techniques. However, the limits of endoscopic resection still have to be fully defined. The purpose of this study was to report on a series of patients presenting with JNA in an effort to further define an optimal treatment algorithm and improve outcomes. Methods: A retrospective review was performed of 18 patients presenting to a tertiary care institution with JNA from 1999 to 2007. Patients were categorized by Andrews stage and data were collected on presentation, operative technique, and postoperative course. Results: All patients underwent preoperative embolization. Stages 1, 2, and one 3a lesions were approached endoscopically while the remainder underwent open resection. In the endoscopic group the intraoperative blood loss was almost half that of the open group (506 versus 934 mL) and the average hospital stay was 1 day less (3 vs. 4 days). Conclusion: Endoscopic resection is reasonable for Andrews stage 1, 2, and select 3a lesions and may allow for less bleeding and a shorter hospital stay. This study supports the current trend of expansion of indications for endoscopic JNA resection.

Original languageEnglish (US)
Pages (from-to)328-330
Number of pages3
JournalAmerican Journal of Rhinology and Allergy
Volume23
Issue number3
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Angiofibroma
Length of Stay
Skull Base
Tertiary Healthcare
Blood Group Antigens
Hemorrhage

Keywords

  • Angiofibroma
  • Embolization
  • Endoscopic surgery
  • Juvenile
  • Nasopharyngeal
  • Neoplasm
  • Skullbase

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Immunology and Allergy

Cite this

Current management of juvenile nasopharyngeal angiofibroma : A tertiary center experience 1999-2007. / Bleier, Benjamin S.; Kennedy, David W.; Palmer, James N.; Chiu, Alexander G; Bloom, Jason D.; O'Malley, Bert W.

In: American Journal of Rhinology and Allergy, Vol. 23, No. 3, 2009, p. 328-330.

Research output: Contribution to journalArticle

Bleier, Benjamin S. ; Kennedy, David W. ; Palmer, James N. ; Chiu, Alexander G ; Bloom, Jason D. ; O'Malley, Bert W. / Current management of juvenile nasopharyngeal angiofibroma : A tertiary center experience 1999-2007. In: American Journal of Rhinology and Allergy. 2009 ; Vol. 23, No. 3. pp. 328-330.
@article{e7a6338e23d04a6ab31c1e7aa3d73366,
title = "Current management of juvenile nasopharyngeal angiofibroma: A tertiary center experience 1999-2007",
abstract = "Background: Over the past 10 years, the management of juvenile nasopharyngeal angiofibroma (JNA) has been redefined because of the improvement of transnasal skull base techniques. However, the limits of endoscopic resection still have to be fully defined. The purpose of this study was to report on a series of patients presenting with JNA in an effort to further define an optimal treatment algorithm and improve outcomes. Methods: A retrospective review was performed of 18 patients presenting to a tertiary care institution with JNA from 1999 to 2007. Patients were categorized by Andrews stage and data were collected on presentation, operative technique, and postoperative course. Results: All patients underwent preoperative embolization. Stages 1, 2, and one 3a lesions were approached endoscopically while the remainder underwent open resection. In the endoscopic group the intraoperative blood loss was almost half that of the open group (506 versus 934 mL) and the average hospital stay was 1 day less (3 vs. 4 days). Conclusion: Endoscopic resection is reasonable for Andrews stage 1, 2, and select 3a lesions and may allow for less bleeding and a shorter hospital stay. This study supports the current trend of expansion of indications for endoscopic JNA resection.",
keywords = "Angiofibroma, Embolization, Endoscopic surgery, Juvenile, Nasopharyngeal, Neoplasm, Skullbase",
author = "Bleier, {Benjamin S.} and Kennedy, {David W.} and Palmer, {James N.} and Chiu, {Alexander G} and Bloom, {Jason D.} and O'Malley, {Bert W.}",
year = "2009",
doi = "10.2500/ajra.2009.23.3322",
language = "English (US)",
volume = "23",
pages = "328--330",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "3",

}

TY - JOUR

T1 - Current management of juvenile nasopharyngeal angiofibroma

T2 - A tertiary center experience 1999-2007

AU - Bleier, Benjamin S.

AU - Kennedy, David W.

AU - Palmer, James N.

AU - Chiu, Alexander G

AU - Bloom, Jason D.

AU - O'Malley, Bert W.

PY - 2009

Y1 - 2009

N2 - Background: Over the past 10 years, the management of juvenile nasopharyngeal angiofibroma (JNA) has been redefined because of the improvement of transnasal skull base techniques. However, the limits of endoscopic resection still have to be fully defined. The purpose of this study was to report on a series of patients presenting with JNA in an effort to further define an optimal treatment algorithm and improve outcomes. Methods: A retrospective review was performed of 18 patients presenting to a tertiary care institution with JNA from 1999 to 2007. Patients were categorized by Andrews stage and data were collected on presentation, operative technique, and postoperative course. Results: All patients underwent preoperative embolization. Stages 1, 2, and one 3a lesions were approached endoscopically while the remainder underwent open resection. In the endoscopic group the intraoperative blood loss was almost half that of the open group (506 versus 934 mL) and the average hospital stay was 1 day less (3 vs. 4 days). Conclusion: Endoscopic resection is reasonable for Andrews stage 1, 2, and select 3a lesions and may allow for less bleeding and a shorter hospital stay. This study supports the current trend of expansion of indications for endoscopic JNA resection.

AB - Background: Over the past 10 years, the management of juvenile nasopharyngeal angiofibroma (JNA) has been redefined because of the improvement of transnasal skull base techniques. However, the limits of endoscopic resection still have to be fully defined. The purpose of this study was to report on a series of patients presenting with JNA in an effort to further define an optimal treatment algorithm and improve outcomes. Methods: A retrospective review was performed of 18 patients presenting to a tertiary care institution with JNA from 1999 to 2007. Patients were categorized by Andrews stage and data were collected on presentation, operative technique, and postoperative course. Results: All patients underwent preoperative embolization. Stages 1, 2, and one 3a lesions were approached endoscopically while the remainder underwent open resection. In the endoscopic group the intraoperative blood loss was almost half that of the open group (506 versus 934 mL) and the average hospital stay was 1 day less (3 vs. 4 days). Conclusion: Endoscopic resection is reasonable for Andrews stage 1, 2, and select 3a lesions and may allow for less bleeding and a shorter hospital stay. This study supports the current trend of expansion of indications for endoscopic JNA resection.

KW - Angiofibroma

KW - Embolization

KW - Endoscopic surgery

KW - Juvenile

KW - Nasopharyngeal

KW - Neoplasm

KW - Skullbase

UR - http://www.scopus.com/inward/record.url?scp=67849104906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67849104906&partnerID=8YFLogxK

U2 - 10.2500/ajra.2009.23.3322

DO - 10.2500/ajra.2009.23.3322

M3 - Article

C2 - 19490810

AN - SCOPUS:67849104906

VL - 23

SP - 328

EP - 330

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 3

ER -